表紙
市場調查報告書
商品編碼
975791

腎性胱胺酸症(nephropathic cystinosis)治療:全球市場預測(2019∼2027年)

Nephropathic Cystinosis Treatment - Global Market Outlook (2019 -2027)

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 150+ Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球腎性胱胺酸症(nephropathic cystinosis)治療的市場規模在2019年估算為2億1,500萬美金。該市場在預測期間內預計將以2.9%的年複合成長率擴大,2027年之前將達到2億7,025萬美元。患者支援的出現,對腎性胱胺酸症患者手計劃的支持以及通過各種計劃提高人們對腎性胱胺酸症的認識是市場增長的主要動力。但是,醫療保健專業人員的短缺阻礙了市場的增長。

本報告提供腎性胱胺酸症(nephropathic cystinosis)治療市場相關調查,提供市場概要,以及各治療類型,各用途,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 簡介
  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 用途分析
  • 新興市場
  • Covid-19的影響

第4章 波特五力分析

第5章 全球腎性胱胺酸症(nephropathic cystinosis)治療市場:各治療類型

  • 簡介
  • 腎臟移植
  • 治療
    • 半胱胺酸乾涸療法
    • 對症療法
    • 全身性乾涸療法

第6章 全球腎性胱胺酸症(nephropathic cystinosis)治療市場:各用途

  • 簡介
  • 門診病人手術中心
  • 診所
  • 醫院
  • 專門/零售藥局

第7章 全球腎性胱胺酸症(nephropathic cystinosis)治療市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他

第8章 主要發展

  • 契約,聯盟,聯合,合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他的重要策略

第9章 企業簡介

  • AVROBIO, Inc
  • Chiesi Farmaceutici S.p.A
  • Eloxx Pharmaceuticals
  • GlaxoSmithKline plc
  • Horizon Therapeutics
  • Leadiant Biosciences, Inc
  • Mylan
  • Recordati Rare Diseases
目錄

According to Stratistics MRC, the Global Nephropathic Cystinosis Treatment Market is accounted for $215.00 million in 2019 and is expected to reach $270.25 million by 2027 growing at a CAGR of 2.9% during the forecast period. Emergence of patient assistance, helping hand programs for nephropathic cystinosis patients and rise in awareness regarding nephropathic cystinosis among people through various programs are the major factors propelling the market growth. However, lack of healthcare professionals is hampering the market growth.

Nephropathic cystinosis is a rare form of disease. It is an inherited (autosomal recessive) lysosomal storage disorder caused by defective transport of the amino acid cystine out of lysosomes. The stored cystine is poorly soluble and crystallizes within the lysosomes of many cell types, leading to widespread tissue and organ damage. Nephropathic cystinosis treatment comprises cysteamine depletion therapy with symptomatic treatment for the disease. At a severe stage, renal transplantation option is adopted.

Based on the treatment type, the therapy segment is going to have a lucrative growth during the forecast period due to the factors such as better efficacy to cure symptoms, delayed renal transplantation, and novel therapy approaches being developed in recent times. The therapy segment is further sub-segmented into systemic depletion therapy and symptomatic therapy. Systemic depletion therapy is a more popular therapy due to being the only effective treatment option for nephropathic cystinosis.

By geography, North America is going to have a lucrative growth during the forecast period due owing to comparatively higher diagnosed patient population for nephropathic cystinosis in the region, availability of U.S. FDA approved products, and research funding for new treatment approaches. For instance, as per Cystinosis Research Network (CRN), cystinosis affects an estimated 2,000 people worldwide with just over 600 of those diagnosed living in the U.S.

Some of the key players profiled in the Nephropathic Cystinosis Treatment Market include: AVROBIO, Inc, Chiesi Farmaceutici S.p.A, Eloxx Pharmaceuticals, GlaxoSmithKline plc, Horizon Therapeutics, Leadiant Biosciences, Inc, Mylan, and Recordati Rare Diseases.

Treatment Types Covered

  • Renal Transplantation
  • Therapy

Applications Covered

  • Ambulatory Surgical Centres
  • Clinics
  • Hospitals
  • Specialty/Retail Pharmacies

Regions Covered

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019 2020, 2024, and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nephropathic Cystinosis Treatment Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Renal Transplantation
  • 5.3 Therapy
    • 5.3.1 Cysteine Depleting Therapy
    • 5.3.2 Symptomatic Therapy
    • 5.3.3 Systemic Depletion Therapy

6 Global Nephropathic Cystinosis Treatment Market, By Application

  • 6.1 Introduction
  • 6.2 Ambulatory Surgical Centres
  • 6.3 Clinics
  • 6.4 Hospitals
  • 6.5 Specialty/Retail Pharmacies

7 Global Nephropathic Cystinosis Treatment Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 AVROBIO, Inc
  • 9.2 Chiesi Farmaceutici S.p.A
  • 9.3 Eloxx Pharmaceuticals
  • 9.4 GlaxoSmithKline plc
  • 9.5 Horizon Therapeutics
  • 9.6 Leadiant Biosciences, Inc
  • 9.7 Mylan
  • 9.8 Recordati Rare Diseases

List of Tables

  • 1 Global Nephropathic Cystinosis Treatment Market Outlook, By Region (2018-2027) ($MN)
  • 2 Global Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
  • 3 Global Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
  • 4 Global Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
  • 5 Global Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
  • 6 Global Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
  • 7 Global Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
  • 8 Global Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
  • 9 Global Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
  • 10 Global Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
  • 11 Global Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
  • 12 Global Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
  • 13 North America Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
  • 14 North America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
  • 15 North America Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
  • 16 North America Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
  • 17 North America Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
  • 18 North America Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
  • 19 North America Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
  • 20 North America Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
  • 21 North America Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
  • 22 North America Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
  • 23 North America Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
  • 24 North America Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
  • 25 Europe Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
  • 26 Europe Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
  • 27 Europe Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
  • 28 Europe Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
  • 29 Europe Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
  • 30 Europe Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
  • 31 Europe Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
  • 32 Europe Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
  • 33 Europe Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
  • 34 Europe Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
  • 35 Europe Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
  • 36 Europe Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
  • 37 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
  • 38 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
  • 39 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
  • 40 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
  • 41 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
  • 42 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
  • 43 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
  • 44 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
  • 45 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
  • 46 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
  • 47 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
  • 48 Asia Pacific Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
  • 49 South America Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
  • 50 South America Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
  • 51 South America Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
  • 52 South America Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
  • 53 South America Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
  • 54 South America Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
  • 55 South America Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
  • 56 South America Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
  • 57 South America Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
  • 58 South America Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
  • 59 South America Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
  • 60 South America Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)
  • 61 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Country (2018-2027) ($MN)
  • 62 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Treatment Type (2018-2027) ($MN)
  • 63 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Cysteine Depleting Therapy (2018-2027) ($MN)
  • 64 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Renal Transplantation (2018-2027) ($MN)
  • 65 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Symptomatic Therapy (2018-2027) ($MN)
  • 66 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Systemic Depletion Therapy (2018-2027) ($MN)
  • 67 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Therapy (2018-2027) ($MN)
  • 68 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Application (2018-2027) ($MN)
  • 69 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Ambulatory Surgical Centres (2018-2027) ($MN)
  • 70 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Clinics (2018-2027) ($MN)
  • 71 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Hospitals (2018-2027) ($MN)
  • 72 Middle East & Africa Nephropathic Cystinosis Treatment Market Outlook, By Specialty/Retail Pharmacies (2018-2027) ($MN)